Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
VRCAVerrica Pharmaceuticals(VRCA) Newsfilter·2024-07-01 19:30
  • Dormer Labs has discontinued the sale of all cantharidin-containing products into the United States - YCANTH is the only commercially available, FDA approved therapy for molluscum contagiosum and is clinically proven to be safe and effective WEST CHESTER, Pa., July 01, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced the settlement of litigation with ...